OpenAI CEO Sam Altman takes diabetes drug metformin as part of his anti-aging routine

OpenAI CEO Sam Altman said he takes diabetes drug metformin as part of his anti-aging regime. Drew Angerer/Getty Images OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. His anti-aging regimen also includes healthy eating, exercising, and getting enough sleep. He's…#openai #samaltman #retrobiosciences #mittechnologyreview #metformin #worldhealth #altman #siliconvalley #conniegibstine #newyorker
Source: Reuters: Health - Category: Consumer Health News Source Type: news